BioCentury
ARTICLE | Financial News

Fund+ closes EUR 125M fund

October 26, 2016 7:00 AM UTC

Fund+ closed its Belgian Life Sciences fund at EUR 125 million ($136.1 million), exceeding its EUR 100 million ($108.9 million) target. Investors included SFPI-FPIM, SRIW, Meusinvest, Spinventure and Sambrinvest, as well as private investors and family offices. Fund+ plans to invest in 12-15 drug development, medical device and in vitro diagnostics companies. ...